( en | de | ru )

 

Disambiguation of "Suissa, Samy"

Author of the publication

copydeleteadd this publication to your clipboard
Immeasurable time bias in observational studies of drug effects on mortality.

. American journal of epidemiology, 168 (3): 329-35 (August 2008)4452<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 7910653; 0 (Anti-Inflammatory Agents); 0 (Glucocorticoids); 2008/05/30 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d&#039;associació.
DOI: 10.1093/aje/kwn135

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Joseph Selvaraj Samy

Mohamed Tayiser Mohamed Mousa Samy

Samy Mostafa

Samy Shamy

Samy Gallego

 

Other publications of authors with the same name

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies., , , , and . Diabetes care, 39 (3): 486-94 (March 2016)Critical appraisal; Bias; Observacionals; Diabetis; Oncologia<br/><br/>Bons gràfics de time bias al material suplementari.Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs., , , , and . Pharmacoepidemiology and drug safety, 16 (8): 845-9 (August 2007)4654<m:linebreak></m:linebreak>LR: 20081121; JID: 9208369; 0 (Central Nervous System Agents); 12794-10-4 (Benzodiazepines); CIN: Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):850-3. PMID: 17636552; ppublish;<m:linebreak></m:linebreak>Mesures d&#039;associació.ACE-I and ARBs in early diabetic nephropathy., , , , , , , , , and . Journal of the renin-angiotensin-aldosterone system : JRAAS, (xx 12 2002)Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , and 17 other author(s). 329 (16): 1376 (2023)Immortal time bias in observational studies of drug effects.. Pharmacoepidemiology and drug safety, 16 (3): 241-9 (March 2007)4793<m:linebreak></m:linebreak>LR: 20071115; CI: (c) 2007; JID: 9208369; 0 (Adrenergic beta-Agonists); 0 (Gastrointestinal Agents); CIN: Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):1036. PMID: 18816873; ppublish;<m:linebreak></m:linebreak>Mesures d&#039;associació; Immortal time bias.The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding., , and . European journal of epidemiology, 27 (2): 77-83 (February 2012)6578<m:linebreak></m:linebreak>JID: 8508062; 2011/03/28 received; 2011/11/23 accepted; 2011/12/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models.How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias., , , , , and . Pharmacoepidemiology and drug safety, (January 2019)Databases; Anàlisi de dades.Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?. Diabetes care, 41 (1): 6-10 (January 2018)Mesures d'associació; Immortal time bias; Diabetis.Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores., , and . Pharmacoepidemiology and drug safety, 26 (4): 459-468 (April 2017)Propensity score; CER; New-user designs; Diabetis.The multitime case-control design for time-varying exposures., , and . Epidemiology (Cambridge, Mass.), 21 (6): 876-83 (November 2010)5909<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 9009644; ppublish;<m:linebreak></m:linebreak>Dissenys híbrids.